FDA Issues Untitled Letter to Althera Pharmaceuticals for Statements Relating to ROSZET® June 23, 2022
FDA Issues Untitled Letter to Bausch Health Companies for Misleading Statements Relating to DUOBRII™ April 19, 2022
OIG Advisory Opinion Alert: Yet Another Favorable Decision for Medical Device Manufacturers March 17, 2022
OIG Advisory Opinion Alert: Yet Another Favorable Decision for Medical Device Manufacturers March 17, 2022
